8. The role of the cervicovaginal microbiome and local immunity in human papillomavirus persistence and precancerous cervical changes

Авторы

  • Y. Kim CF “University Medical Center”, Astana, Kazakhstan https://orcid.org/0009-0005-8040-325X
  • T. Ukybassova CF “University Medical Center”, Astana, Kazakhstan
  • G. Bapayeva CF “University Medical Center”, Astana, Kazakhstan
  • K. Kongrtay CF “University Medical Center”, Astana, Kazakhstan
  • N. Kamzayeva CF “University Medical Center”, Astana, Kazakhstan
  • B. Imankulova CF “University Medical Center”, Astana, Kazakhstan

DOI:

https://doi.org/10.35805/BSK2025I008

Загрузки

Аннотация

Background. This study provides a detailed review of the interactions between the cervicovaginal microbiome, local immune responses, and human papillomavirus infection outcomes.

Methods. A literature review was conducted covering the period from 2015 to 2024 using the PubMed, Scopus, Embase, and Google Scholar databases. The search included keywords such as human papillomavirus, cervicovaginal microbiome, dysbiosis, cytokines, cervical cancer, Boolean operators, and Medical Subject Headings terms for search refinement.Inclusion criteria: Peer-reviewed publications in English and Russian focusing on the cervicovaginal microbiome, immune responses, human papillomavirus persistence, and cervical neoplasia; observational studies, clinical trials, and reviews. Exclusion criteria: Non-peer-reviewed sources, gray literature, and studies unrelated to microbiome-immune system interactions or human papillomavirus outcomes.

Results. Lactobacillus species, particularly L. crispatus, play a key role in maintaining an acidic vaginal environment that modulates local immunity and promotes human papillomavirus clearance. Dysbiosis, characterized by an overgrowth of Gardnerella, Prevotella, and Sneathia, leads to inflammation, disruption of the epithelial barrier, and human papillomavirus persistence. Hormonal fluctuations and environmental factors influence these processes, determining infection outcomes and disease progression.

Conclusion. The cervicovaginal microbiome and local immunity are integral to human papillomavirus pathogenesis and cervical cancer prevention.

Ключевые слова

cervicovaginal microbiome, human papillomavirus, local immune responses, cervical cancer

Библиографические ссылки

  1. Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global bur-den of cervical cancer associated with HIV. Lancet Glob Health. Feb 2021;9(2):e161-e169. doi:10.1016/S2214-109X(20)30459-9
  2. Guida F, Kidman R, Ferlay J, et al. Global and regional estimates of or-phans attributed to maternal can-cer mortality in
  3. Zhang YM, Jiang YH, Li HW, Li XZ, Zhang QL. Purification and char-acterization of Lactobacillus plan-tarum-derived bacteriocin with activity against Staphylococcus ar-genteus planktonic cells and biofilm. J Food Sci. Jun 2022;87(6):2718-2731. doi:10.1111/1750-3841.16148
  4. Kyrgiou M, Mitra A, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. Jan 2017;179:168-182. doi:10.1016/j.trsl.2016.07.004
  5. Diop K, Bretelle F, Raoult D, Fenol-lar F. 'Corynebacterium fournierii,' a new bacterial species isolated from the vaginal sample of a patient with bacterial vaginosis. New Mi-crobes New Infect. Jul 2017;18:6-7. doi:10.1016/j.nmni.2017.03.005
  6. Diop K, Cadoret F, Nguyen TT, et al. Vaginimicrobium propionicum gen. nov., sp. nov., a novel propionic acid bacterium derived from human vag-inal discharge. Int J Syst Evol Mi-crobiol. Jul 2020;70(7):4091-4097. doi:10.1099/ijsem.0.004106
  7. Keburiya LK, Smolnikova VY, Pri-putnevich TV, et al. Correction to: Does the uterine microbiota affect the reproductive outcomes in wom-en with recurrent implantation fail-ures? BMC Womens Health. May 15 2023;23(1):265. doi:10.1186/s12905-023-02302-6
  8. Goulenok T, Francois C, Ferre VM, Mageau A, Sacre K, Group AS. Vag-inal self-sampling for human pap-illomavirus to improve cervical cancer screening in patients with immune-mediated inflammatory diseases. Eur J Intern Med. Jan 12 2025; doi:10.1016/j.ejim.2025.01.002
  9. Hulsman CJM, Gao H, Kruepunga N, et al. The development of the exter-nal genitals in female human em-bryos and foetuses. Part 2: Vaginal vestibule, anal canal, perineal raphe and perineal cutaneous muscles. J Anat. Feb 2025;246(2):205-221. doi:10.1111/joa.14150
  10. France MT, Ma B, Gajer P, et al. VA-LENCIA: a nearest centroid classifi-cation method for vaginal microbial communities based on composition. Microbiome. Nov 23 2020;8(1):166. doi:10.1186/s40168-020-00934-6
  11. Keburiya LK, Smolnikova VY, Pri-putnevich TV, et al. Does the uterine microbiota affect the reproductive outcomes in women with recurrent implantation failures? BMC Wom-ens Health. May 14 2022;22(1):168. doi:10.1186/s12905-022-01750-w
  12. Darbandi A, Asadi A, Mahdizade Ari M, et al. Bacteriocins: Properties and potential use as antimicrobials. J Clin Lab Anal. Jan 2022;36(1):e24093. doi:10.1002/jcla.24093
  13. Asadi A, Lohrasbi V, Abdi M, et al. The probiotic properties and poten-tial of vaginal Lactobacillus spp. iso-lated from healthy women against some vaginal pathogens. Lett Appl Microbiol. May 2022;74(5):752-764. doi:10.1111/lam.13660
  14. Witkin SS, Linhares IM. Why do lactobacilli dominate the hu-
  15. Gao H, Liu Q, Wang X, et al. Deci-phering the role of female repro-ductive tract microbiome in repro-ductive health: a review. Front Cell Infect Microbiol. 2024;14:1351540. doi:10.3389/fcimb.2024.1351540
  16. Amabebe E, Anumba DOC. The Vag-inal Microenvironment: The Physio-logic Role of Lactobacilli. Front Med (Lausanne). 2018;5:181. doi:10.3389/fmed.2018.00181
  17. Zare H, Izadi Amoli R, Zaboli F, Rezapour M, Kaboosi H. The pheno-typic and genotypic antibiotic sus-ceptibility of vaginal Lactobacillus with potential probiotic properties isolated from healthy women in northern Iran. Iran J Microbiol. Apr 2024;16(2):227-235. doi:10.18502/ijm.v16i2.15356
  18. Laniewski P, Barnes D, Goulder A, et al. Linking cervicovaginal immune signatures, HPV and microbiota com-position in cervical carcinogenesis in non-Hispanic and Hispanic wom-en. Sci Rep. May 15 2018;8(1):7593. doi:10.1038/s41598-018-25879-7
  19. Pruski P, Lewis HV, Lee YS, et al. As-sessment of microbiota:host inter-actions at the vaginal mucosa inter-face. Methods. Oct 1 2018;149:74-84. doi:10.1016/j.ymeth.2018.04.022
  20. Zhang Y, Wu X, Li D, et al. HPV-as-sociated cervicovaginal microbi-ome and host metabolome char-acteristics. BMC Microbiol. Mar 22 2024;24(1):94. doi:10.1186/s12866-024-03244-1
  21. Smith SB, Ravel J. The vaginal mi-crobiota, host defence and repro-ductive physiology. J Physiol. Jan 15 2017;595(2):451-463. doi:10.1113/JP271694
  22. Xue J, Wang Y, Chen C, Zhu X, Zhu H, Hu Y. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk hu-man papillomavirus infection. Can-cer Med. Feb 2018;7(2):297-306. doi:10.1002/cam4.1279
  23. Audirac-Chalifour A, Torres-Poveda K, Bahena-Roman M, et al. Cervi-cal Microbiome and Cytokine Pro-file at Various Stages of Cervical Cancer: A Pilot Study. PLoS One. 2016;11(4):e0153274. doi:10.1371/journal.pone.0153274
  24. Ntuli L, Mtshali A, Mzobe G, Lieben-berg LJ, Ngcapu S. Role of Immunity and Vaginal Microbiome in Clear-ance and Persistence of Human Papillomavirus Infection. Front Cell Infect Microbiol. 2022;12:927131. doi:10.3389/fcimb.2022.927131
  25. Dong M, Dong Y, Bai J, et al. Inter-actions between microbiota and cer-vical epithelial, immune, and mucus barrier. Front Cell Infect Microbi-ol. 2023;13:1124591. doi:10.3389/fcimb.2023.1124591
  26. Di Paola M, Sani C, Clemente AM, et al. Characterization of cervico-vagi-nal microbiota in women developing persistent high-risk Human Pap-illomavirus infection. Sci Rep. Aug 31 2017;7(1):10200. doi:10.1038/s41598-017-09842-6
  27. Liu Y, Zhou Y, Mao T, et al. The rela-tionship between menopausal syn-drome and gut microbes. BMC Wom-ens Health. Nov 8 2022;22(1):437. doi:10.1186/s12905-022-02029-w
  28. Hu J, Wu Y, Quan L, et al. Research of cervical microbiota alterations with human papillomavirus infec-tion status and women age in San-menxia area of China. Front Micro-biol. 2022;13:1004664. doi:10.3389/fmicb.2022.1004664
  29. Auriemma RS, Scairati R, Del Vec-chio G, et al. The Vaginal Microbi-ome: A Long Urogenital Colonization Throughout Woman Life. Front Cell Infect Microbiol. 2021;11:686167. doi:10.3389/fcimb.2021.686167
  30. Kaur H, Merchant M, Haque MM, Mande SS. Crosstalk Between Fe-male Gonadal Hormones and Vaginal Microbiota Across Various Phases of Women's Gynecological Lifecy-cle. Front Microbiol. 2020;11:551. doi:10.3389/fmicb.2020.00551
  31. Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillo-mavirus infection and cervical in-traepithelial neoplasia: what do we know and where are we going next? Microbiome. Nov 1 2016;4(1):58. doi:10.1186/s40168-016-0203-0
  32. Mirmonsef P, Modur S, Burgad D, et al. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and post-menopausal women. Menopause. Jul 2015;22(7):702-9. doi:10.1097/GME.0000000000000397
  33. Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbi-ome. Maturitas. Sep 2016;91:42-50. doi:10.1016/j.maturitas.2016.05.015
  34. Chan CK, Aimagambetova G, Uky-bassova T, Kongrtay K, Azizan A. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives. J Oncol. 2019;2019:3257939. doi:10.1155/2019/3257939
  35. Li Y, Yu T, Yan H, et al. Vaginal Mi-crobiota and HPV Infection: Novel Mechanistic Insights and Therapeu-tic Strategies. Infect Drug Resist. 2020;13:1213-1220. doi:10.2147/IDR.S210615
  36. Norenhag J, Du J, Olovsson M, Ver-straelen H, Engstrand L, Brus-selaers N. The vaginal microbi-ota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analy-sis. BJOG. Jan 2020;127(2):171-180. doi:10.1111/1471-0528.15854
  37. Sharifian K, Shoja Z, Jalilvand S. The interplay between human papillo-mavirus and vaginal microbiota in cervical cancer development. Virol J. Apr 19 2023;20(1):73. doi:10.1186/s12985-023-02037-8
  38. Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Mi-crobiol. 2022;12:963868. doi:10.3389/fcimb.2022.963868

Опубликован

2025-03-31

Выпуск

№ 1 (2025)

Раздел

Статьи